title: [Qianlieping capsule plus alpha-blocker for chronic non-bacterial prostatitis: analysis of 220 cases].
abstract: OBJECTIVE
  To investigate the clinical effects of Qianlieping Capsule combined with alpha-receptor blocker tamsulosin on chronic non-bacterial prostatitis (CNBP).
  
  
  METHODS
  We assigned 220 CNBP patients to three groups to receive oral Qianlieping Capsule (2.0 g tid) plus alpha-receptor blocker tamsulosin (0.2 mg qd) (n = 98), Qianlieping Capsule alone at 2.0 g tid (n = 66), and tamsulosin alone at 0.2 mg qd (n = 56) , respectively. After 6 weeks of medication, we assessed the therapeutic effects according to the NIH-CPSI scores and the number of small particles of lecithin (SPL) in the prostatic fluid after treatment.
  
  
  RESULTS
  Qianlieping Capsule alone increased the number of SPL by 46.9% and reduced the NIH-CPSI score by 24.4%. Combination of Qianlieping and tamsulosin more significantly increased the number of SPL (61.4%) and decreased the NIH-CPSI score (42.3%) than tamsulosin alone (33.7% and 28.6%) (P < 0.01).
  
  
  CONCLUSIONS
  Qianlieping Capsule chronic is effective for chronic non-bacterial prostatitis, and the combination of Qianlieping Capsule with tamsulosin produces even better effect than tamsulosin alone.
authors.affiliation: Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi 710004, China. glutjp@163.com
authors.forename: Jian-Ping
authors.initials: JP
authors.lastname: Li
authors.forename: Tie
authors.initials: T
authors.lastname: Chong
authors.forename: Hai-Wen
authors.initials: HW
authors.lastname: Chen
authors.forename: He-Cheng
authors.initials: HC
authors.lastname: Li
authors.forename: Jun
authors.initials: J
authors.lastname: Cao
authors.forename: Peng
authors.initials: P
authors.lastname: Zhang
authors.forename: Hong-Liang
authors.initials: HL
authors.lastname: Li
mesh_terms: D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D002214:Capsules; D002908:Chronic Disease; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008517:Phytotherapy; D011472:Prostatitis / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use; D000077409:Tamsulosin; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000317:Adrenergic alpha-Antagonists; D002214:Capsules; D004365:Drugs, Chinese Herbal; D013449:Sulfonamides; D000077409:Tamsulosin